FDA May Wield Prosecutorial Authority More Frequently

Device companies can expect more active legal prosecution by FDA for off-label and product safety issues as the agency improves its ability to track products on the market and as the activity of industry whistleblowers grows, according to government and agency staffers

More from Archive

More from Medtech Insight